Shopping Cart 0
Cart Subtotal
USD 0

Healthcare Providers in the Czech Republic

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 350

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 700

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 1050
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Healthcare Providers in the Czech Republic

Summary

Healthcare Providers in the Czech Republic industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Czech Republic healthcare providers market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key Highlights

The healthcare providers sector is valued as total expenditure on healthcare in each country. This includes final consumption spending on healthcare goods and services.

The Czech healthcare providers sector had total revenues of $12.9bn in 2016, representing a compound annual growth rate (CAGR) of 2.1% between 2012 and 2016.

The outpatient care segment was the sector's most lucrative in 2016, with total revenues of $4.1bn, equivalent to 31.9% of the sector's overall value. The Inpatient care segment contributed revenues of $3.9bn in 2016, equating to 30.4% of the sector's aggregate value.

The Czech government has revealed intentions of turning public hospital operators to non-for profit basis, also merging some of them. This is crucial for the sector on which total expenditure is based on government spending by 85% approximately.

Scope

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the healthcare providers market in the Czech Republic

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the healthcare providers market in the Czech Republic

Leading company profiles reveal details of key healthcare providers market players' global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Czech Republic healthcare providers market with five year forecasts

Reasons to buy

What was the size of the Czech Republic healthcare providers market by value in 2016?

What will be the size of the Czech Republic healthcare providers market in 2021?

What factors are affecting the strength of competition in the Czech Republic healthcare providers market?

How has the market performed over the last five years?

What are the main segments that make up the Czech Republic's healthcare providers market?

READ MORE

Table Of Content

Scope

Table of Contents

Executive Summary

Market value

Market value forecast

Category segmentation

Geography segmentation

Market rivalry

Market Overview

Market definition

Market analysis

Market Data

Market value

Market Segmentation

Category segmentation

Geography segmentation

Market Outlook

Market value forecast

Five Forces Analysis

Summary

Buyer power

Supplier power

New entrants

Threat of substitutes

Degree of rivalry

Leading Companies

Affidea BV

AGEL a.s.

MediClinic a.s.

Macroeconomic Indicators

Country data

Methodology

Industry associations

Related MarketLine research

Appendix

About MarketLine


List Of Figure

List of Figures

Figure 1: Czech Republic healthcare providers sector value: $ billion, 2012-16

Figure 2: Czech Republic healthcare providers sector category segmentation: % share, by value, 2016

Figure 3: Czech Republic healthcare providers sector geography segmentation: % share, by value, 2016

Figure 4: Czech Republic healthcare providers sector value forecast: $ billion, 2016-21

Figure 5: Forces driving competition in the healthcare providers sector in the Czech Republic, 2016

Figure 6: Drivers of buyer power in the healthcare providers sector in the Czech Republic, 2016

Figure 7: Drivers of supplier power in the healthcare providers sector in the Czech Republic, 2016

Figure 8: Factors influencing the likelihood of new entrants in the healthcare providers sector in the Czech Republic, 2016

Figure 9: Factors influencing the threat of substitutes in the healthcare providers sector in the Czech Republic, 2016

Figure 10: Drivers of degree of rivalry in the healthcare providers sector in the Czech Republic, 2016


List Of Table

List of Tables

Table 1: Czech Republic healthcare providers sector value: $ billion, 2012-16

Table 2: Czech Republic healthcare providers sector category segmentation: $ billion, 2016

Table 3: Czech Republic healthcare providers sector geography segmentation: $ billion, 2016

Table 4: Czech Republic healthcare providers sector value forecast: $ billion, 2016-21

Table 5: Affidea BV: key facts

Table 6: AGEL a.s.: key facts

Table 7: MediClinic a.s.: key facts

Table 8: Czech Republic size of population (million), 2012-16

Table 9: Czech Republic gdp (constant 2005 prices, $ billion), 2012-16

Table 10: Czech Republic gdp (current prices, $ billion), 2012-16

Table 11: Czech Republic inflation, 2012-16

Table 12: Czech Republic consumer price index (absolute), 2012-16

Table 13: Czech Republic exchange rate, 2012-16

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Affidea BVAGEL a.s.MediClinic a.s.

Healthcare Providers in the Czech Republic

Summary

Healthcare Providers in the Czech Republic industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Czech Republic healthcare providers market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key Highlights

The healthcare providers sector is valued as total expenditure on healthcare in each country. This includes final consumption spending on healthcare goods and services.

The Czech healthcare providers sector had total revenues of $12.9bn in 2016, representing a compound annual growth rate (CAGR) of 2.1% between 2012 and 2016.

The outpatient care segment was the sector's most lucrative in 2016, with total revenues of $4.1bn, equivalent to 31.9% of the sector's overall value. The Inpatient care segment contributed revenues of $3.9bn in 2016, equating to 30.4% of the sector's aggregate value.

The Czech government has revealed intentions of turning public hospital operators to non-for profit basis, also merging some of them. This is crucial for the sector on which total expenditure is based on government spending by 85% approximately.

Scope

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the healthcare providers market in the Czech Republic

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the healthcare providers market in the Czech Republic

Leading company profiles reveal details of key healthcare providers market players' global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Czech Republic healthcare providers market with five year forecasts

Reasons to buy

What was the size of the Czech Republic healthcare providers market by value in 2016?

What will be the size of the Czech Republic healthcare providers market in 2021?

What factors are affecting the strength of competition in the Czech Republic healthcare providers market?

How has the market performed over the last five years?

What are the main segments that make up the Czech Republic's healthcare providers market?

READ MORE

Scope

Table of Contents

Executive Summary

Market value

Market value forecast

Category segmentation

Geography segmentation

Market rivalry

Market Overview

Market definition

Market analysis

Market Data

Market value

Market Segmentation

Category segmentation

Geography segmentation

Market Outlook

Market value forecast

Five Forces Analysis

Summary

Buyer power

Supplier power

New entrants

Threat of substitutes

Degree of rivalry

Leading Companies

Affidea BV

AGEL a.s.

MediClinic a.s.

Macroeconomic Indicators

Country data

Methodology

Industry associations

Related MarketLine research

Appendix

About MarketLine


List Of Figure

List of Figures

Figure 1: Czech Republic healthcare providers sector value: $ billion, 2012-16

Figure 2: Czech Republic healthcare providers sector category segmentation: % share, by value, 2016

Figure 3: Czech Republic healthcare providers sector geography segmentation: % share, by value, 2016

Figure 4: Czech Republic healthcare providers sector value forecast: $ billion, 2016-21

Figure 5: Forces driving competition in the healthcare providers sector in the Czech Republic, 2016

Figure 6: Drivers of buyer power in the healthcare providers sector in the Czech Republic, 2016

Figure 7: Drivers of supplier power in the healthcare providers sector in the Czech Republic, 2016

Figure 8: Factors influencing the likelihood of new entrants in the healthcare providers sector in the Czech Republic, 2016

Figure 9: Factors influencing the threat of substitutes in the healthcare providers sector in the Czech Republic, 2016

Figure 10: Drivers of degree of rivalry in the healthcare providers sector in the Czech Republic, 2016


List Of Table

List of Tables

Table 1: Czech Republic healthcare providers sector value: $ billion, 2012-16

Table 2: Czech Republic healthcare providers sector category segmentation: $ billion, 2016

Table 3: Czech Republic healthcare providers sector geography segmentation: $ billion, 2016

Table 4: Czech Republic healthcare providers sector value forecast: $ billion, 2016-21

Table 5: Affidea BV: key facts

Table 6: AGEL a.s.: key facts

Table 7: MediClinic a.s.: key facts

Table 8: Czech Republic size of population (million), 2012-16

Table 9: Czech Republic gdp (constant 2005 prices, $ billion), 2012-16

Table 10: Czech Republic gdp (current prices, $ billion), 2012-16

Table 11: Czech Republic inflation, 2012-16

Table 12: Czech Republic consumer price index (absolute), 2012-16

Table 13: Czech Republic exchange rate, 2012-16

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

Affidea BVAGEL a.s.MediClinic a.s.